Company Filing History:
7 out of 923 
1 out of 5,450 
Years Active: 2011-2021
Title: The Innovative Contributions of Keith Koch
Introduction
Keith Koch is a notable inventor based in Erie, Colorado. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target apoptosis signal-regulating kinase (ASK1). With a total of 7 patents to his name, Koch's work has the potential to impact the treatment of various medical conditions.
Latest Patents
Koch's latest patents focus on apoptosis signal-regulating kinase inhibitors. These inventions relate to compounds of Formula (I), which exhibit ASK1 inhibitory activity. The compounds are designed to be useful in treating ASK1-mediated conditions, including autoimmune disorders, inflammatory diseases, cardiovascular diseases, and neurodegenerative diseases. Additionally, the patents cover pharmaceutical compositions that include these compounds and methods for their preparation.
Career Highlights
Throughout his career, Keith Koch has worked with prominent organizations such as Gilead Sciences, Inc. and the University of Texas System. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Koch has had the opportunity to work alongside notable colleagues, including Britton Kenneth Corkey and Michael Graupe. These collaborations have further enriched his research and development efforts.
Conclusion
Keith Koch's innovative work in the field of pharmaceuticals, particularly in the area of apoptosis signal-regulating kinase inhibitors, showcases his dedication to advancing medical science. His contributions have the potential to lead to significant advancements in the treatment of various diseases.